{"filing":{"accession_number":"0001630627-26-000014","cik":"0001630627","ticker":"TMCI","company_name":"TREACE MEDICAL CONCEPTS, INC.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"tmci-20260519.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1630627/000163062726000014/tmci-20260519.htm"},"events":[{"id":9928,"run_id":8703,"accession_number":"0001630627-26-000014","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents final voting tabulations for three proposals: election of Class II directors (Lance A. Berry, Elizabeth S. Hanna, Jane E. Kiernan), advisory vote on executive compensation, and ratification of Grant Thornton LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.","company_name":"TREACE MEDICAL CONCEPTS, INC.","ticker":"TMCI","filing_date":"2026-05-20","form":"8-K","submitted_at":null,"items":[{"id":758,"accession_number":"0001630627-26-000014","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents final voting tabulations for three proposals: election of Class II directors (Lance A. Berry, Elizabeth S. Hanna, Jane E. Kiernan), advisory vote on executive compensation, and ratification of Grant Thornton LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:08.639575+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":758,"accession_number":"0001630627-26-000014","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 19, 2026. The filing presents final voting tabulations for three proposals: election of Class II directors (Lance A. Berry, Elizabeth S. Hanna, Jane E. Kiernan), advisory vote on executive compensation, and ratification of Grant Thornton LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of fundamental corporate governance matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:56:08.639575+00:00","company_name":"TREACE MEDICAL CONCEPTS, INC.","ticker":"TMCI","filing_date":"2026-05-20"}]}